These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 1825480

  • 1. Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation.
    Warren HS, Skipsey LJ.
    Immunology; 1991 Jan; 72(1):150-7. PubMed ID: 1825480
    [Abstract] [Full Text] [Related]

  • 2. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M, Ståhls A, Seppälä I, Timonen T.
    Nat Immun Cell Growth Regul; 1991 Jan; 10(5):265-77. PubMed ID: 1836835
    [Abstract] [Full Text] [Related]

  • 3. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE, Fehniger TA, Caligiuri MA.
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [Abstract] [Full Text] [Related]

  • 4. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A, Lanier LL, Cwirla S, Phillips JH.
    J Immunol; 1989 Nov 15; 143(10):3183-91. PubMed ID: 2530273
    [Abstract] [Full Text] [Related]

  • 5. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J.
    Eur J Immunol; 1992 Jan 15; 22(1):1-6. PubMed ID: 1370410
    [Abstract] [Full Text] [Related]

  • 6. Activation of cloned human natural killer cells via Fc gamma RIII.
    Werfel T, Uciechowski P, Tetteroo PA, Kurrle R, Deicher H, Schmidt RE.
    J Immunol; 1989 Feb 15; 142(4):1102-6. PubMed ID: 2464637
    [Abstract] [Full Text] [Related]

  • 7. A subset of CD16-natural killer cells without antibody-dependent cellular cytotoxicity function.
    Schubert J, Heiken H, Jacobs R, Delany P, Witte T, Schmidt RE.
    Nat Immun Cell Growth Regul; 1990 Feb 15; 9(2):103-11. PubMed ID: 2141105
    [Abstract] [Full Text] [Related]

  • 8. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G, Fisch P, Prieve AF, Sosman JA, Hank JA, Sondel PM.
    Cancer Res; 1989 Jul 01; 49(13):3680-8. PubMed ID: 2471587
    [Abstract] [Full Text] [Related]

  • 9. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
    Saito S, Morii T, Enomoto M, Sakakura S, Nishikawa K, Narita N, Ichijo M.
    Cell Immunol; 1993 Dec 01; 152(2):605-13. PubMed ID: 7504983
    [Abstract] [Full Text] [Related]

  • 10. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells.
    Warren HS, Skipsey LJ.
    Immunology; 1991 Sep 01; 74(1):78-85. PubMed ID: 1834549
    [Abstract] [Full Text] [Related]

  • 11. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K, Salmeron MA, Kornbluth J, Bucana C, Itoh K.
    J Immunol; 1991 Apr 01; 146(7):2453-60. PubMed ID: 1900882
    [Abstract] [Full Text] [Related]

  • 12. Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes.
    Phillips JH, Chang CW, Lanier LL.
    Eur J Immunol; 1991 Apr 01; 21(4):895-9. PubMed ID: 1826887
    [Abstract] [Full Text] [Related]

  • 13. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C, Vitté-Mony I, Lang P, Pico J, Hercend T, Bertoglio J.
    Leukemia; 1992 May 01; 6(5):470-6. PubMed ID: 1375700
    [Abstract] [Full Text] [Related]

  • 14. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
    Pricop L, Rabinowich H, Morel PA, Sulica A, Whiteside TL, Herberman RB.
    J Immunol; 1993 Sep 15; 151(6):3018-29. PubMed ID: 7690792
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-8 production by CD16-CD56bright natural killer cells in the human early pregnancy decidua.
    Saito S, Kasahara T, Sakakura S, Enomoto M, Umekage H, Harada N, Morii T, Nishikawa K, Narita N, Ichijo M.
    Biochem Biophys Res Commun; 1994 Apr 15; 200(1):378-83. PubMed ID: 7513162
    [Abstract] [Full Text] [Related]

  • 17. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J, Broxmeyer HE.
    Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743
    [Abstract] [Full Text] [Related]

  • 18. Induction of activation antigens on human natural killer cells mediated through the Fc-gamma receptor.
    Harris DT, Travis WW, Koren HS.
    J Immunol; 1989 Oct 01; 143(7):2401-6. PubMed ID: 2528593
    [Abstract] [Full Text] [Related]

  • 19. Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.
    Ellis TM, Creekmore SP, McMannis JD, Braun DP, Harris JA, Fisher RI.
    Cancer Res; 1988 Nov 15; 48(22):6597-602. PubMed ID: 2902918
    [Abstract] [Full Text] [Related]

  • 20. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA, Weiner GJ.
    J Immunol Methods; 2005 Sep 15; 304(1-2):88-99. PubMed ID: 16109421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.